Authors: Laffin, RJ Chan, DW Tanasijevic, MJ Fischer, GA Markus, W Miller, J Matarrese, P Sokoll, LJ Bruzek, DJ Eneman, J Nelson, J Bray, KR Huang, J Loveland, KG

Citation: Rj. Laffin et al., Hybritech total and free prostate-specific antigen assays developed for the Beckman Coulter access automated chemiluminescent immunoassay system: A multicenter evaluation of analytical performance, CLIN CHEM, 47(1), 2001, pp. 129-132

Authors: Catalona, WJ Southwick, PC Slawin, KM Partin, AW Brawer, MK Flanigan, RC Patel, A Richie, JP Walsh, PC Scardino, PT Lange, PH Gasior, GH Loveland, KG Bray, KR

Citation: Wj. Catalona et al., Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, UROLOGY, 56(2), 2000, pp. 255-260

Authors: Chan, DW Kelley, CA Ratliff, TL D'Agostino, D Ritchey, J Lamb, DJ Beck, J Lott, N Wener, MH Daum, P Henkin, RE Kaske, DN Golightly, DW McBride, J Layco, G Ota, MK Tanasijevic, MJ Grudzien, C Woodrum, DL Bray, KR Southwick, PC Gasior, GH Loveland, KG

Citation: Dw. Chan et al., Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine theclinical utility of percentage of free prostate-specific antigen, CLIN CHEM, 45(10), 1999, pp. 1863-1865